Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele

被引:42
作者
Biasiotto, G
Roetto, A
Daraio, F
Polotti, A
Gerardia, GM
Girelli, D
Cremonesi, L
Arosioa, P
Camaschella, C
机构
[1] Univ Brescia, Dipartimento Materno Infantile & Tecnol Biomed, Brescia, Italy
[2] Univ Turin, Azienda Osped San Luigi, Dipartimento Sci Clin & Biol, Turin, Italy
[3] Univ Verona, Dept Clin & Expt Med, I-37134 Verona, Italy
[4] IRCCS H San Raffaele, Unite Genom Diagnosis Human Pathol, Milan, Italy
关键词
iron; hemochromatosis; hepcidin; hemojuvelin; modifier genes; DHPLC;
D O I
10.1016/j.bcmd.2004.08.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
HFE-hemochromatosis is the most common form of hereditary hemochromatosis. The disorder is associated with the homozygous C282Y mutation and has variable phenotype, being modulated by environmental and genetic factors. Candidate modifier genes are hemojuvelin and hepcidin, which are responsible for juvenile hemochromatosis. We used DHPLC to scan mutations in these genes in a cohort of unrelated patients with C282Y mutation. They consisted of 136 C282Y homozygous, 43 heterozygous, and 42 C282Y/H63D compound heterozygous, plus 62 controls subjects. Mutations and polymorphisms were found in 16 patients and 4 controls. Abnormally high indices of iron status were found in subjects C282Y/H63D heterozygous for the N196K hemojuvelin mutation and the -72C>T hepcidin substitution. The already described G71D mutation of hepcidin did not induce evident modification of the C282Y/H63D phenotype. The data show that heterozygous mutations of the hemojuvelin gene contribute like those of hepcidin to the phenotypic heterogeneity of hemochromatosis. However, they are rare and explain only a minor portion of the variable penetrance of the disorder. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:338 / 343
页数:6
相关论文
共 24 条
  • [1] Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload
    Biasiotto, G
    Belloli, S
    Ruggeri, G
    Zanella, I
    Gerardi, G
    Corrado, M
    Gobbi, E
    Albertini, A
    Arosio, P
    [J]. CLINICAL CHEMISTRY, 2003, 49 (12) : 1981 - 1988
  • [2] Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis
    Bridle, KR
    Frazer, DM
    Wilkins, SJ
    Dixon, JL
    Purdie, DM
    Crawford, DHG
    Subramaniam, VN
    Powell, LW
    Anderson, GJ
    Ramm, GA
    [J]. LANCET, 2003, 361 (9358) : 669 - 673
  • [3] MAGNETIC-SUSCEPTIBILITY MEASUREMENT OF HUMAN IRON STORES
    BRITTENHAM, GM
    FARRELL, DE
    HARRIS, JW
    FELDMAN, ES
    DANISH, EH
    MUIR, WA
    TRIPP, JH
    BELLON, EM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (27) : 1671 - 1675
  • [4] Juvenile hemochromatosis
    Camaschella, C
    Roetto, A
    De Gobbi, M
    [J]. SEMINARS IN HEMATOLOGY, 2002, 39 (04) : 242 - 248
  • [5] Cox T, 2002, LANCET, V360, P412, DOI 10.1016/S0140-6736(02)09582-X
  • [6] A homozygous HAMP mutation in a multiply consanguineous family with pseudo-dominant juvenile hemochromatosis
    Delatycki, MB
    Allen, KJ
    Gow, P
    MacFarlane, J
    Radomski, C
    Thompson, J
    Hayden, MR
    Goldberg, YP
    Samuels, ME
    [J]. CLINICAL GENETICS, 2004, 65 (05) : 378 - 383
  • [7] HUANG FW, 2004, BLOOD 0511
  • [8] HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype
    Jacolot, S
    Le Gac, G
    Scotet, V
    Quere, I
    Mura, C
    Ferec, C
    [J]. BLOOD, 2004, 103 (07) : 2835 - 2840
  • [9] Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis
    Lanzara, C
    Roetto, A
    Daraio, F
    Rivard, S
    Ficarella, R
    Simard, H
    Cox, TM
    Cazzola, M
    Piperno, A
    Gimenez-Roqueplo, AP
    Grammatico, P
    Volinia, S
    Gasparini, P
    Camaschella, C
    [J]. BLOOD, 2004, 103 (11) : 4317 - 4321
  • [10] The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype
    Le Gac, G
    Scotet, V
    Ka, C
    Gourlaouen, I
    Bryckaert, L
    Jacolot, S
    Mura, C
    Férec, C
    [J]. HUMAN MOLECULAR GENETICS, 2004, 13 (17) : 1913 - 1918